Form 4: Dolby Laboratories Executive Shriram Revankar Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Shriram Revankar, a Senior Vice President at Dolby Laboratories, reported the acquisition of restricted stock units and stock options, as well as the disposal of shares to cover taxes.

Summary

  • Shriram Revankar, a Senior Vice President at Dolby Laboratories, filed a Form 4 detailing changes in his beneficial ownership of company stock.
  • On December 16, 2024, Revankar acquired 18,141 restricted stock units (RSUs) under the company's 2020 Stock Plan, which vest over four years.
  • He also acquired 9,070 performance-based restricted stock units (PSUs) that vest based on performance criteria over a three-year period ending December 13, 2027.
  • Additionally, Revankar was granted an option to purchase 31,890 shares of Class A Common Stock, vesting over 40 months.
  • Revankar disposed of 3,364 shares of Class A Common Stock at $79.18 per share to cover withholding taxes related to the vesting of RSUs.
  • Following these transactions, Revankar directly owns 81,413 shares of Class A Common Stock and holds rights to 66,676 shares through RSUs and 60,000 shares through PSUs.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and does not indicate any significant positive or negative events. The sentiment is neutral to slightly positive due to the alignment of executive interests with shareholder value.

Positives

  • The grant of 18,141 restricted stock units and 31,890 stock options indicates continued alignment of executive interests with shareholder value.
  • The performance-based restricted stock units (PSUs) incentivize long-term performance and are tied to the company's performance relative to the S&P Mid Cap 400 Index.
  • The vesting schedule of the RSUs and stock options encourages long-term commitment from the executive.

Negatives

  • The disposal of 3,364 shares to cover taxes, while standard, slightly reduces Revankar's direct shareholding.

Risks

  • The performance-based restricted stock units (PSUs) are subject to the company's performance relative to the S&P Mid Cap 400 Index, which introduces uncertainty in the final vesting amount.
  • The value of the stock options is dependent on the future stock price of Dolby Laboratories.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon continued employment and, in the case of PSUs, the company's performance relative to the S&P Mid Cap 400 Index. The executive's future holdings will depend on these factors.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It reflects the standard compensation practices of using equity-based awards to align executive interests with shareholder value.

Comparison to Industry Standards

  • Equity-based compensation, including restricted stock units and stock options, is a common practice among publicly traded technology companies like Dolby Laboratories.
  • Companies such as Apple, Microsoft, and Google also use similar compensation structures to incentivize their executives.
  • The vesting schedules and performance-based criteria are also typical for executive compensation packages in the tech industry.
  • The use of the S&P Mid Cap 400 Index as a benchmark for performance-based units is a common practice to measure relative performance.

Stakeholder Impact

  • The transactions have a minor positive impact on shareholders by aligning executive interests with company performance.
  • The vesting of equity awards may have a positive impact on employee morale.

Next Steps

  • The restricted stock units will vest over the next four years.
  • The performance-based restricted stock units will vest based on performance over the three-year period ending December 13, 2027.
  • The stock options will vest over the next 40 months.

Key Dates

DateDescription
12/16/2024Date of the reported transactions, including the grant of RSUs, PSUs, and stock options, as well as the disposal of shares for tax purposes.
12/13/2027End date of the three-year performance period for the performance-based restricted stock units (PSUs).
12/18/2024Date the Form 4 was signed.

Keywords

Dolby Laboratories, Shriram Revankar, stock options, restricted stock units, performance-based units, Form 4, insider trading, executive compensation, equity awards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.